Literature DB >> 28342286

Switching Aurora-A kinase on and off at an allosteric site.

Richard Bayliss1, Selena G Burgess1, Patrick J McIntyre2.   

Abstract

Protein kinases are central players in the regulation of cell cycle and signalling pathways. Their catalytic activities are strictly regulated through post-translational modifications and protein-protein interactions that control switching between inactive and active states. These states have been studied extensively using protein crystallography, although the dynamic nature of protein kinases makes it difficult to capture all relevant states. Here, we describe two recent structures of Aurora-A kinase that trap its active and inactive states. In both cases, Aurora-A is trapped through interaction with a synthetic protein, either a single-domain antibody that inhibits the kinase or a hydrocarbon-stapled peptide that activates the kinase. These structures show how the distinct synthetic proteins target the same allosteric pocket with opposing effects on activity. These studies pave the way for the development of tools to probe these allosteric mechanisms in cells.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  allostery; kinase inhibitor; protein kinase; protein-protein interaction

Mesh:

Substances:

Year:  2017        PMID: 28342286     DOI: 10.1111/febs.14069

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

1.  Allosteric modulation of a human protein kinase with monobodies.

Authors:  Adelajda Zorba; Vy Nguyen; Akiko Koide; Marc Hoemberger; Yuejiao Zheng; Steffen Kutter; Chansik Kim; Shohei Koide; Dorothee Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

Review 2.  Dynamic regulatory features of the protein tyrosine kinases.

Authors:  Neha Amatya; David Yin-Wei Lin; Amy H Andreotti
Journal:  Biochem Soc Trans       Date:  2019-08-08       Impact factor: 5.407

3.  CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.

Authors:  Haoyan Li; Yin Wang; Kevin Lin; Varadha Balaji Venkadakrishnan; Martin Bakht; Wei Shi; Chenling Meng; Jie Zhang; Kaitlyn Tremble; Xin Liang; Jian H Song; Xu Feng; Vivien Van; Pingna Deng; Jared K Burks; Ana Aparicio; Khandan Keyomarsi; Junjie Chen; Yue Lu; Himisha Beltran; Di Zhao
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

4.  Mitotic spindle association of TACC3 requires Aurora-A-dependent stabilization of a cryptic α-helix.

Authors:  Selena G Burgess; Manjeet Mukherjee; Sarah Sabir; Nimesh Joseph; Cristina Gutiérrez-Caballero; Mark W Richards; Nicolas Huguenin-Dezot; Jason W Chin; Eileen J Kennedy; Mark Pfuhl; Stephen J Royle; Fanni Gergely; Richard Bayliss
Journal:  EMBO J       Date:  2018-03-06       Impact factor: 11.598

5.  New landscapes and horizons in hepatocellular carcinoma therapy.

Authors:  Melchiorre Cervello; Maria R Emma; Giuseppa Augello; Antonella Cusimano; Lydia Giannitrapani; Maurizio Soresi; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Alessandro Gulino; Beatrice Belmonte; Giuseppe Montalto; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

Review 6.  Allosteric inhibition of LRRK2, where are we now.

Authors:  Ahmed Soliman; Fatma Nihan Cankara; Arjan Kortholt
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

7.  Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine.

Authors:  Matthew J Byrne; Nazia Nasir; Christine Basmadjian; Chitra Bhatia; Rory F Cunnison; Katherine H Carr; Corine Mas-Droux; Sharon Yeoh; Céline Cano; Richard Bayliss
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.857

8.  A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor.

Authors:  Qiaohua Zhu; Xinfa Yu; Zhi-Wei Zhou; Meihua Luo; Chengyu Zhou; Zhi-Xu He; Yong Chen; Shu-Feng Zhou
Journal:  J Cancer       Date:  2018-05-24       Impact factor: 4.207

Review 9.  The functional diversity of Aurora kinases: a comprehensive review.

Authors:  Estelle Willems; Matthias Dedobbeleer; Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Bernard Rogister
Journal:  Cell Div       Date:  2018-09-19       Impact factor: 5.130

10.  Dynamics of human protein kinase Aurora A linked to drug selectivity.

Authors:  Warintra Pitsawong; Vanessa Buosi; Renee Otten; Roman V Agafonov; Adelajda Zorba; Nadja Kern; Steffen Kutter; Gunther Kern; Ricardo Ap Pádua; Xavier Meniche; Dorothee Kern
Journal:  Elife       Date:  2018-06-14       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.